Studies evaluating the GH-IGF-I-IGFBP-3 system in patients with RA have yielded contradictory and inconsistent results [7,9,13-18], in part because of differences in the ages, genders, and numbers of patients studied, disease activity, and use of glucocorticoids and other disease-modifying agents. Here, GH1 is linked to rheumatoid arthritis.